Related Experiment Video
Updated: Mar 14, 2026
11:54
Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles
Published on: March 13, 2017
9.9K
Multiplex SNP genotyping in whole blood using an integrated microfluidic lab-on-a-chip
L Zhang1, Q Cai1, R S Wiederkehr1
1Department of Life Science Technology, imec, Leuven, 3000, Belgium. Lei.Zhang@imec.be.
Lab on a Chip
|October 8, 2016
Summary
A new integrated microsystem enables cost-effective, on-demand genotyping from blood. This technology advances pharmacogenetics for personalized medicine by simplifying single nucleotide polymorphism (SNP) detection at the point-of-care.
Area of Science:
- Biotechnology
- Genomics
- Medical Diagnostics
Background:
- Pharmacogenetics aims to personalize medicine by predicting drug response based on genetic makeup.
- Current genetic testing methods are often expensive, complex, and require specialized personnel, limiting widespread adoption.
- Accessible and cost-effective genotyping technologies are crucial for realizing the potential of pharmacogenetics.
Purpose of the Study:
- To develop a silicon-based integrated microsystem for direct detection of multiple single nucleotide polymorphisms (SNPs) from human blood.
- To demonstrate the feasibility of on-chip genotyping for clinically relevant SNPs using the developed microsystem.
- To provide a rapid, reproducible, and accurate sample-to-answer solution for multiplex SNP profiling.
Main Methods:
- An integrated microsystem was designed, incorporating a blood lysis chamber, cross-flow filter, T-junction mixer, and microreactor for quantitative polymerase chain reaction (qPCR).
- The microsystem was used for on-chip genotyping of two SNPs in the human CYP2C9 gene directly from blood samples.
- TaqMan assays and a sequence of primer/probe plugs were employed for simultaneous detection of multiple SNPs.
Main Results:
- Successful on-chip genotyping of two clinically relevant SNPs in the CYP2C9 gene was achieved directly from human blood.
- The microsystem demonstrated simultaneous detection of multiple SNPs, indicating potential for broader application.
- The developed method is rapid, reproducible, and accurate, suitable for point-of-care settings.
Conclusions:
- The integrated microsystem offers a cost-effective and accessible solution for multiplex SNP profiling.
- This technology facilitates sample-to-answer genotyping, moving pharmacogenetics-based precision medicine closer to clinical reality.
- The platform is adaptable for detecting numerous SNPs, enhancing its utility in personalized medicine applications.
